About: http://webisa.webdatacommons.org/328184977

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	r continues. ???We feel the ability of EpiScreen to recognize these problematic antibodies early in their development is an important tool for insuring highly successful biologics.
http://www.w3.org/ns/prov#wasQuotedFrom	genengnews.com